POCKET NALOXONE Trademark

Trademark Overview

On Wednesday, January 11, 2023, a trademark application was filed for POCKET NALOXONE with the United States Patent and Trademark Office. The USPTO has given the POCKET NALOXONE trademark a serial number of 97750644. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, September 23, 2024. This trademark is owned by Pocket Naloxone Corp.. The POCKET NALOXONE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the rapid treatment of opioid toxicity and overdosage
pocket naloxone

General Information

Serial Number97750644
Word MarkPOCKET NALOXONE
Filing DateWednesday, January 11, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, September 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the rapid treatment of opioid toxicity and overdosage
NOT AVAILABLE"NALOXONE"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 2, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePocket Naloxone Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBethesda, MD 20816
Party NamePocket Naloxone Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBethesda, MD 20816

Trademark Events

Event DateEvent Description
Saturday, January 14, 2023NEW APPLICATION ENTERED
Thursday, February 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 20, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 4, 2023ASSIGNED TO EXAMINER
Tuesday, October 10, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 10, 2023NON-FINAL ACTION E-MAILED
Tuesday, October 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 12, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, January 12, 2024EXAMINERS AMENDMENT E-MAILED
Friday, January 12, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 12, 2024EXAMINER'S AMENDMENT ENTERED
Friday, January 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 31, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 24, 2024DIVISIONAL REQUEST RECEIVED
Friday, May 24, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, September 10, 2024DIVISIONAL PROCESSING COMPLETE
Tuesday, September 10, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 10, 2024CORRECTED NOA E-MAILED
Monday, September 23, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2024SOU EXTENSION 1 FILED
Monday, September 23, 2024SOU EXTENSION 1 GRANTED

Related Keywords

naloxone pocket toxicity overdosage opioid treatment preparations rapid pharmaceutical